Van Hulzen Asset Management LLC lowered its position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 2.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,928 shares of the semiconductor company’s stock after selling 1,697 shares during the period. Lam Research makes up approximately 2.2% of Van Hulzen Asset Management LLC’s portfolio, making the stock its 9th largest position. Van Hulzen Asset Management LLC’s holdings in Lam Research were worth $31,602,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in LRCX. Brighton Jones LLC boosted its position in shares of Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the last quarter. Caxton Associates LLP bought a new position in Lam Research during the 1st quarter valued at about $239,000. Gabelli Funds LLC bought a new position in Lam Research during the 2nd quarter valued at about $253,000. NewEdge Advisors LLC boosted its holdings in shares of Lam Research by 2.7% during the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after acquiring an additional 2,661 shares during the last quarter. Finally, Osterweis Capital Management Inc. grew its stake in shares of Lam Research by 5,206.7% in the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock worth $77,000 after acquiring an additional 781 shares during the period. 84.61% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the stock. Citigroup restated a “buy” rating and set a $450.00 price objective (up from $315.00) on shares of Lam Research in a research report on Wednesday, June 17th. Sanford C. Bernstein raised their price target on Lam Research from $325.00 to $340.00 and gave the company an “outperform” rating in a report on Thursday, May 21st. Morgan Stanley dropped their price target on Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. B. Riley Financial lowered their target price on shares of Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Finally, Barclays reaffirmed an “overweight” rating and set a $335.00 target price (up from $275.00) on shares of Lam Research in a research note on Thursday, June 11th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Lam Research has an average rating of “Moderate Buy” and a consensus price target of $361.81.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Analyst sentiment remains favorable, with Wall Street maintaining a consensus “Moderate Buy” view. Recent coverage also highlights Lam Research’s exposure to artificial intelligence, high-bandwidth memory and advanced DRAM investment, which could support demand for its semiconductor-manufacturing equipment. Consensus rating article Lam Research momentum article
- Positive Sentiment: Lam’s latest quarterly results exceeded expectations, with earnings per share of $1.82 versus the $1.69 consensus and revenue of $6.72 billion versus $6.66 billion. Revenue increased 30% year over year, and management’s next-quarter earnings guidance points to continued growth. These results underpin the long-term bullish case. Three reasons investors favor Lam Research
- Neutral Sentiment: Lam Research presented at Citi’s 2026 Global TMT Conference. The event could provide additional commentary on customer spending, AI-related demand and industry trends, but the supplied report does not identify a material new forecast or announcement. Citi conference transcript
- Negative Sentiment: The stock’s recent rise—nearly tripling over the past year and gaining about 45% in six months—has left investors vulnerable to profit-taking. With a high earnings multiple, even a normal market pullback or weaker risk appetite can pressure LRCX despite strong operating results. Lam Research larger market drop
- Negative Sentiment: Several articles describe clinical studies involving imaging, MRI or compression therapy. These items appear to be incorrectly associated with Lam Research and do not represent developments in the semiconductor-equipment company; investors should disregard them when assessing LRCX.
Insider Buying and Selling
In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the company’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the transaction, the insider owned 42,462 shares in the company, valued at approximately $12,843,056.52. The trade was a 10.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.31% of the stock is currently owned by company insiders.
Lam Research Stock Performance
NASDAQ:LRCX opened at $315.84 on Thursday. The firm has a market capitalization of $395.22 billion, a PE ratio of 54.83, a PEG ratio of 1.27 and a beta of 1.85. The stock’s fifty day moving average is $315.51 and its 200 day moving average is $293.41. Lam Research Corporation has a fifty-two week low of $104.61 and a fifty-two week high of $438.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same quarter in the prior year, the firm posted $1.33 earnings per share. The business’s revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, sell-side analysts anticipate that Lam Research Corporation will post 9.33 earnings per share for the current year.
Lam Research Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be paid a dividend of $0.33 per share. This is a positive change from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research’s payout ratio is currently 18.06%.
Lam Research Company Profile
Lam Research Corporation is a semiconductor equipment company that develops and manufactures systems used in the fabrication of integrated circuits. Its equipment supports key wafer-processing steps, including deposition, etch, wafer cleaning, and related processes used to create and connect the microscopic features found on semiconductor devices.
The company serves semiconductor manufacturers producing a range of products, including memory, logic, and specialty chips. In addition to manufacturing equipment, Lam Research provides installation, maintenance, spare parts, upgrades, technical support, and other services intended to help customers operate and improve their fabrication facilities.
Founded in 1980, Lam Research is headquartered in Fremont, California, and serves customers through a global network of offices, engineering facilities, and support operations.
Further Reading
- Five stocks we like better than Lam Research
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
